Page last updated: 2024-09-04

vx 497 and ag-213

vx 497 has been researched along with ag-213 in 1 studies

Compound Research Comparison

Studies
(vx 497)
Trials
(vx 497)
Recent Studies (post-2010)
(vx 497)
Studies
(ag-213)
Trials
(ag-213)
Recent Studies (post-2010) (ag-213)
253722404

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)ag-213 (IC50)
Epidermal growth factor receptorHomo sapiens (human)3.222
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)5.7
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)3.0667
Protein kinase C alpha typeHomo sapiens (human)3
Protein-glutamine gamma-glutamyltransferase 2Homo sapiens (human)3
M-phase inducer phosphatase 1Homo sapiens (human)3
Tyrosine-protein kinase JAK3Homo sapiens (human)3
Receptor-type tyrosine-protein phosphatase etaHomo sapiens (human)3
Receptor protein-tyrosine kinase Homo sapiens (human)3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandraratna, RA; Nagpal, S; Thacher, SM; Tsang, KY; Vasudevan, J1

Reviews

1 review(s) available for vx 497 and ag-213

ArticleYear
New dermatological agents for the treatment of psoriasis.
    Journal of medicinal chemistry, 2001, Feb-01, Volume: 44, Issue:3

    Topics: Administration, Topical; Anti-Inflammatory Agents; Cholecalciferol; Clinical Trials as Topic; Glucocorticoids; Humans; Immunosuppressive Agents; Ligands; Methotrexate; Psoriasis; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Vitamin A

2001